From: The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
Statin
Atorvastatin 20 mg
Atorvastatin 40 mg
% of LDLc reduction
43%a
49%a
Lovastatin
80 mg
-
Pitavastatin
4 mg
Pravastatin
Rosuvastatin
5 mg
10 mg
Simvastatin
40 mg